Related Experiment Video
Updated: Feb 24, 2026

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Urate promotes SNCA/α-synuclein clearance via regulating mTOR-dependent macroautophagy
Yu-Lan Sheng1, Xing Chen1, Xiao-Ou Hou1
1Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China; Institute of Neuroscience, Soochow University, Suzhou 215123, China.
Uric acid (UA) enhances autophagy by inhibiting mTOR, reducing alpha-synuclein accumulation in Parkinson's disease models. This suggests UA-elevating agents could be a potential Parkinson's therapy.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Serum urate levels are lower in Parkinson's disease (PD) patients, suggesting a protective role.
- The precise mechanism of urate's effect on PD pathogenesis remains unclear.
Purpose of the Study:
- To investigate the mechanism by which uric acid (UA) influences autophagy and alpha-synuclein (SNCA) accumulation in Parkinson's disease models.
- To explore the potential of UA as a therapeutic strategy for PD.
Main Methods:
- PC12 cells and SNCAA53T transgenic mice were used to study autophagy markers (LC3-II, P62) and SNCA levels.
- Experiments involved treatments with uric acid (UA), Bafilomycin A1, and an mTOR activator (3BDO).
- Autophagy activation was assessed via LC3 puncta and autophagosome/autolysosome formation.
Main Results:
- UA treatment dose- and time-dependently enhanced autophagy in PC12 cells by increasing LC3-II and decreasing P62.
- UA-induced autophagy occurred via mTOR inhibition and ULK1 activation, independent of lysosomal function.
- UA reduced SNCA/α-synuclein accumulation in vitro and in vivo, an effect blocked by lysosomal inhibition.
- UA modulated autophagy markers and reduced SNCA in the midbrain of SNCAA53T mice.
Conclusions:
- Uric acid activates autophagy through mTOR-dependent signaling, ameliorating SNCA accumulation.
- These findings support the potential of urate-elevating agents as a therapeutic strategy for Parkinson's disease.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
PI3K/mTOR/AKT Signaling Pathway
Regulation of Nuclear Protein Sorting
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Neural Regulation

